Vinci Pharmaceuticals Funding: $8M Round (Oct 2026)

Recent changes

Oct 10, 2026Oct 10, 2026Raised $8M Series A Pulse 2.0
Oct 10, 2026Oct 10, 2026Vinci Pharmaceuticals Raises $8M For Eye Implant Pulse story

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Oct 10, 2026	Series A	$8M	—	Dynagrow CapitalEPIPLANT	Pulse story

Latest Pulse

Oct 10, 2026Vinci Pharmaceuticals Raises $8M For Eye ImplantVinci Pharmaceuticals raised more than $8 million in Series A funding, reportedly led by Dynagrow Capital, to advance EPIPLANT, a bioerodible implant designed to deliver drugs to retinal tissue without repeat injections.→

Coverage Timeline

newest first

Oct 10, 2026FUNDINGVinci Pharmaceuticals Raises $8M For Eye Implant$8M Series A→

All Coverage

FUNDING· Oct 10, 2026

Vinci Pharmaceuticals Raises $8M For Eye Implant

FUNDING$8M Series A

Vinci Pharmaceuticals Raises $8M For Eye Implant

Vinci Pharmaceuticals raised more than $8 million in Series A funding, reportedly led by Dynagrow Capital, to advance EPIPLANT, a bioerodible implant designed to deliver drugs to retinal tissue without repeat injections.

Oct 10, 2026DEEP DIVE

Related Companies

Same sector

Scribe Therapeutics Attovia Therapeutics Apnimed Retension Pharmaceuticals Braveheart Bio Eli Lilly

Sources & methodologyshow

Where these figures come from

Pulse 2.0Value Add VC data1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction